FFRangio System vs CVI42

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

CVI42

by Circle Cardiovascular Imaging Inc.

AI Verdict

Tool A (FFRangio System) is specifically designed for real-time functional assessment during PCI using angiograms, providing wire-free FFR guidance to optimize interventional decisions. Tool B (CVI42) is a comprehensive imaging platform for analyzing cardiac and vascular CT and MRI data, focusing on diagnosis, planning, and patient care through detailed anatomical and physiological insights. While both contribute to coronary artery disease management, FFRangio is an interventional guidance tool, whereas CVI42 is a diagnostic and planning imaging analysis solution.

Choose FFRangio System if…

Choose the FFRangio System if your primary need is real-time, wire-free functional assessment of coronary artery disease directly within the cath lab. This tool is ideal for quickly optimizing and confirming PCI decisions by providing immediate FFR guidance and insights into lesion impact without the need for invasive pressure wires or vasoactive drugs.

View FFRangio System →

Choose CVI42 if…

Choose CVI42 if you require a comprehensive, AI-enabled platform for advanced diagnostic analysis and planning across various cardiac and vascular imaging modalities, including CT and MRI. This solution is best suited for detailed pre-procedural assessment, in-depth coronary plaque characterization, and advanced CMR automation to enhance diagnosis and patient care.

View CVI42 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	CVI42
Pricing	Contact vendor for pricing information.	Starts at $5,000 per license.
Deployment	SaaS, on-prem, hybrid	On-premise (standalone workstation or client/server)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	CVI42
Name	FFRangio System	CVI42
Company	CathWorks	CIRCLE CARDIOVASCULAR IMAGING
Tagline	A New Era in Coronary Physiology	One Platform for All Your Advanced Cardiac Imaging Needs
Primary Focus	Wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in coronary artery disease.	AI-enabled software platform for comprehensive cardiac and vascular imaging analysis (CT and MRI).
Specialties	Cardiology	Cardiology, Cardiothoracic Surgery, Radiology

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and CVI42.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of the FFRangio System versus CVI42?

The FFRangio System delivers wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease. CVI42 is an AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools.

How do these tools differ in the type of imaging data they analyze and their core technology?

The FFRangio System utilizes artificial intelligence to aid in quick angiogram analysis, providing FFRangio values from C-arm angiography systems. CVI42 is an AI-enabled software platform designed for advanced analysis of cardiac and vascular imaging obtained from CT and MRI scans.

Does either tool offer advantages in reducing the invasiveness of cardiac procedures?

Yes, the FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter for FFR assessment. CVI42 focuses on non-invasive post-acquisition analysis of CT and MRI images.

What specific types of cardiac and vascular analysis can each tool perform?

The FFRangio System provides real-time FFRangio values, simulated pullback curves, lesion impact assessment, and an integrated sizing tool. CVI42 offers AI-automated coronary lumen and wall segmentation, comprehensive coronary plaque analysis, advanced CMR automation (like T1 mapping and 4D flow pre-processing), and vascular CT analysis and planning tools.

Which medical specialties are primarily targeted by each tool?

The FFRangio System is primarily targeted at Cardiology. CVI42 supports Cardiology, Cardiothoracic Surgery, and Radiology.